TLDR Few dermatologists in Ontario accept OHIP referrals for hair loss, leading to long wait times and high fees.
A study assessing the acceptance of OHIP referrals for hair loss by dermatologists in Ontario found that only 38.38% of the 284 contacted offices accepted such referrals, while 48.59% did not, and 13.03% were unreachable. The average wait time for accepted referrals was approximately 4.5 months, and non-OHIP consultation fees ranged from $135 to $299 CAD. Some dermatologists only accepted referrals for specific conditions like alopecia areata and male androgenetic alopecia. The findings highlight concerns about accessibility to care for hair loss and suggest a need for further research into the factors affecting referral acceptance.
7 citations,
October 2021 in “Indian Journal of Plastic Surgery” Hair loss patients need psychological counseling to cope better.
36 citations,
November 2018 in “American Journal of Clinical Dermatology” Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.
7 citations,
January 2018 in “Skin appendage disorders” The document suggests recognizing "trichiatrists" as doctors specializing in hair and scalp health, using evidence-based treatments.
144 citations,
July 2015 in “Clinical, Cosmetic and Investigational Dermatology” Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.
24 citations,
March 2017 in “Journal of The European Academy of Dermatology and Venereology” Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.
15 citations,
February 2003 in “British Journal of Dermatology” The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.
14 citations,
September 2015 in “PubMed” Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.
6 citations,
June 2021 in “EClinicalMedicine” ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.
3 citations,
September 2021 in “EClinicalMedicine” ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.
